Skip to main content
. 2022 Feb 8;20:32. doi: 10.1186/s12957-021-02477-y

Fig. 1.

Fig. 1

A Expression of TMED2 in different cancers, as determined via the TIMER2.0 system. B OS and C PPS analyses between LUAD patients with high and low TMED2 expression, as determined using the Kaplan-Meier plotter system. D GSEA of TMED2 with lung cancer poor survival. E GSEA of TMED2 with apoptosis in LUAD